Our sequencing analyses revealed that, after antigen exposure and before arthritis onset, these cells showed heightened expression of T cell activation genes (Nr4a1, Egr1-3, Irf4) despite impaired proximal TCR signaling capacity and diminished expression of key tolerogenic markers compared with WT cells. The gene discussed is IRF4; the disease is arthritic joint disease.